Browse Tag

stock news

Aspire Biopharma (ASBP) Jumps on $100M Equity Line and Q3 Filing – What Matters on November 14, 2025

Aspire Biopharma (ASBP) Jumps on $100M Equity Line and Q3 Filing – What Matters on November 14, 2025

Micro‑cap biotech Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) is back in the spotlight today after securing a new $100 million equity line of credit and releasing its Q3 2025 10‑Q, sending the stock sharply higher in pre‑market trading. ASBP stock among Friday’s biggest pre‑market movers Aspire Biopharma shares were one of the most active health‑care names in U.S. pre‑market trade on Friday. StockTitan data places Aspire’s current market capitalization at roughly $5.3 million, with a public float of about 27.2 million shares and insider ownership above 30%. Stock Titan Today’s move comes as investors digest two major disclosures: a fresh
14 November 2025
CAVA Stock News Today (Nov 8, 2025): Guidance Cut Fallout, Analyst Target Resets, and What’s Next for CAVA Group (NYSE: CAVA)

CAVA Stock News Today (Nov 8, 2025): Guidance Cut Fallout, Analyst Target Resets, and What’s Next for CAVA Group (NYSE: CAVA)

This week at a glance: why CAVA is in the headlines Analyst moves since the print These updates follow earlier, more bullish initiations earlier in the year, underscoring how quickly sentiment has cooled as traffic moderates. Investopedia+1 By the numbers — Q3 FY2025 (company reported) What to watch next Quick take CAVA’s long runway (415 units vs. a national whitespace) remains intact, but near‑term comps are caught in a consumer downdraft affecting much of fast casual. Management’s choice to protect brand equity—rather than chase discount traffic—means investors will be watching Q4 trends closely to see if loyalty, menu news and
Breaking: Eos Energy & MN8 Secure Huge 750 MWh U.S. Battery Storage Deal – Are Stocks Set to Skyrocket?

Eos Energy (EOSE) News Today: Price Target Uplift, Fresh Downgrade, and 70% Warrant Surge — What’s Moving the Stock (Nov 8, 2025)

Updated: November 8, 2025 Key takeaways What’s new today (Nov. 8, 2025) Downgrade lands after the run-up. MarketBeat carried an alert that Wall Street Zen cut EOSE to “Sell” early Saturday, noting the stock’s sharp appreciation and summarizing the existing split in coverage (a mix of Buy/Hold/Sell ratings and an average target near the low teens). While not a bulge-bracket call, the downgrade adds a counterweight to bullish revisions that followed earnings. MarketBeat Fresh transcript color: cash, guidance, and warrants. A newly posted Q3 2025 earnings call transcript highlights management’s stance that execution into Q4 supports the low end of
Marvell Technology Stock Soars on AI Boom: Latest Price, Hot News & 2025 Outlook

Marvell Technology (MRVL) Slides as SoftBank Takeover Buzz Fades — Stock News for November 7, 2025

Summary: Marvell Technology (NASDAQ: MRVL) traded lower on Friday after yesterday’s pop tied to reports that SoftBank explored a takeover earlier this year. Investors are now refocusing on fundamentals and the company’s next earnings catalyst in early December. MarketWatch+1 MRVL stock today: price action at a glance As of 19:27 UTC on November 7, 2025, MRVL changed hands at $88.64, down about 5% on the day. The session ranged between $85.12 and $94.16 after opening at $91.68. For context, Reuters lists a 52‑week range of $47.09–$127.48. Reuters What’s driving the move Takeover chatter hangover. On Thursday, multiple outlets relayed a
Intel (INTC) Pops as Tesla Mulls Chip Partnership; Pre‑Market Rebounds on Musk Comments — Nov. 7, 2025

Intel Stock Today (INTC): Musk Floats Tesla–Intel AI Chip Talks; Key AI Exec Departs to AMD — Price, News & What to Watch (Nov 7, 2025)

Published: November 7, 2025 Key takeaways Intel stock price today (Nov 7, 2025) Intel shares are hovering near flat on the day: $37.19 at 18:49 UTC (down $0.06 from yesterday), day range $36.97–$38.33, open $37.37. That leaves INTC mid‑range versus its 52‑week band of $17.66–$42.48. Intraday volume stood near 63.5M by the latest print. Reuters Why INTC is on watch today 1) Musk floats possible Tesla–Intel AI chip collaboration At Tesla’s annual meeting, Elon Musk said Tesla will likely need a “gigantic chip fab” for future AI processors and mused about “worth having discussions” with Intel as a potential manufacturing
Pinterest Stock Plunges 18% on Earnings Miss – Can AI and Record Users Fuel a Rebound?

Pinterest (PINS) plunges as holiday‑quarter outlook disappoints; ARK Invest buys the dip — what to know today (Nov. 6, 2025)

Pinterest, Inc. (NYSE: PINS) is under heavy pressure again today after tepid holiday‑quarter guidance overshadowed a solid Q3 and record user growth. Shares are trading around the mid‑$20s intraday, extending yesterday’s sell‑off as investors reset expectations for year‑end ad demand and monetization.  Investopedia+1 The quick take What happened Pinterest’s Q3 2025 print delivered on growth but missed on profitability: revenue hit $1.049B (+17% YoY) and MAUs reached 600M, but adjusted EPS of $0.38 came in below consensus. The miss and a softer‑than‑hoped Q4 outlook triggered the downdraft.  MarketWatch+3Pinterest Investor Relations+3Pinterest Investor Relations+3 By the numbers (Q3): Why Wall Street is nervous Holiday‑quarter guidance. Management guided Q4 revenue to $1.313B–$1.338B, which
XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Stock Price Skyrockets on Acquisition News Shares of XORTX Therapeutics Inc. (NASDAQ: XRTX) surged on October 17, 2025 after the nano-cap biotech announced a strategic acquisition in its core therapeutic area. The stock rocketed up immediately following the morning press release, spiking up to 40% in early trading. By midday, XRTX was changing hands at just over $1.20 per share (up from around $0.86 the prior day) ragingbull.com. It eventually closed about 21% higher on Friday tipranks.com – a dramatic move for a company that had been trading quietly near the $1 level. This rally was accompanied by an
Diagnex Inc. (DGNX) Stock Skyrockets in 2025 – An Epic ESG Tech Rally and What’s Next

Diginex (DGNX) Stock Skyrockets as New ESG Deals Roll In – Key October 3 Updates

Stock Price & Trading Activity (Oct 3, 2025) On Thursday, Oct. 2, DGNX jumped to $15.80 (close) from $14.56 the day prior stockanalysis.com. Thursday’s intraday range was roughly $14.88–$16.64, and volume hit 671,462 shares stockanalysis.com (versus ~348K on Oct. 1 stockanalysis.com). The stock has formed a broad trading range in recent weeks (the 52-week high is $19.54 on Sept. 22, up from a low near $0.06 last year benzinga.com), so yesterday’s gain brought DGNX back toward its recent highs. As of this morning (Oct. 3 open), the stock is trading around $15.75–$15.80, roughly flat with yesterday’s close (technical forecasts had predicted an opening ~+$0.17% at
Go toTop